Graft-vs-Host Disease in a Liver Transplant Patient With COVID-19 Infection

Graft-vs-host disease (GVHD) after liver transplant is a rare complication with high mortality outcomes. Because of the rarity of occurrence, there is no standardized consensus for treatment. Early recognition of symptoms and a multidisciplinary approach with input from transplant hepatology and hem...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiparizoska, Sara, Nguyen, Veronica, Rangnekar, Amol S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875985/
https://www.ncbi.nlm.nih.gov/pubmed/36713282
http://dx.doi.org/10.14309/crj.0000000000000971
Descripción
Sumario:Graft-vs-host disease (GVHD) after liver transplant is a rare complication with high mortality outcomes. Because of the rarity of occurrence, there is no standardized consensus for treatment. Early recognition of symptoms and a multidisciplinary approach with input from transplant hepatology and hematology is important to determine a treatment plan and improve outcomes. We present a unique case of a 49-year-old woman who developed GVHD during a coronavirus disease 2019 (COVID-19) infection 3 months after receiving a liver transplant. More data are needed to determine whether COVID-19 infection itself correlates with a risk of developing GVHD.

Ejemplares similares